Cabergoline
Cabergoline Tablets, USP
Approved
Approval ID
89ec147b-a6fe-49bb-9af5-52fc2ce5db7f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 12, 2023
Manufacturers
FDA
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cabergoline
PRODUCT DETAILS
NDC Product Code50090-5834
Application NumberANDA204735
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateNovember 19, 2019
Generic NameCabergoline
INGREDIENTS (5)
CABERGOLINEActive
Quantity: 0.5 mg in 1 1
Code: LL60K9J05T
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT